Applied DNA Sciences Proxy Statement Filed

TL;DR

APDN proxy filed for Aug 2 meeting - vote on directors & auditors.

AI Summary

Applied DNA Sciences Inc. filed its definitive proxy statement on June 21, 2024, for its annual meeting of stockholders scheduled for August 2, 2024. The filing outlines proposals to be voted on, including the election of directors and the ratification of the appointment of its independent registered public accounting firm. The company is seeking shareholder approval for various corporate actions necessary for its ongoing operations and strategic initiatives.

Why It Matters

This filing is crucial for shareholders as it details the agenda for the upcoming annual meeting, including key votes that will shape the company's future leadership and financial oversight.

Risk Assessment

Risk Level: medium — Proxy statements can indicate upcoming strategic shifts or financial decisions that may impact the company's stock price.

Key Numbers

• 20240802 — Annual Meeting Date (Shareholders will vote on proposals at this meeting.)
• 20240621 — Filing Date (The date the definitive proxy statement was submitted to the SEC.)

Key Players & Entities

• APPLIED DNA SCIENCES INC (company) — Registrant
• 0001104659-24-073780.txt (document) — Filing document identifier
• 20240621 (date) — Filing date
• 20240802 (date) — Annual meeting date
• 0000744452 (company_id) — Central Index Key

FAQ

Key Financial Figures

• $10,000 — reed to pay Kingsdale Advisors a fee of $10,000 plus reimburse them for certain out-of-

Filing Documents

• tm2416972-1_def14a.htm (DEF 14A) — 181KB
• lg_applieddna-4c.jpg (GRAPHIC) — 11KB
• px_24specialmeeting01-bw.jpg (GRAPHIC) — 202KB
• px_24specialmeeting02-bw.jpg (GRAPHIC) — 244KB
• 0001104659-24-073780.txt ( ) — 751KB

From the Filing

DEF 14A 1 tm2416972-1_def14a.htm DEF 14A tm2416972-1_def14a - none - 2.3906336s TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 Applied DNA Sciences, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. TABLE OF CONTENTS APPLIED DNA SCIENCES, INC. 50 HEALTH SCIENCES DRIVE STONY BROOK, NEW YORK 11790 (631) 240-8800 June 21, 2024 Dear Fellow Stockholder: You are cordially invited to attend a Special Meeting of Stockholders (the " Special Meeting ") of Applied DNA Sciences, Inc. (" Applied DNA Sciences ," the " Company ," " we " or " us ") to be held at 10:00 a.m., Eastern Time , on Friday, August 2, 2024 . We are very pleased that the Special Meeting will be a completely virtual meeting of stockholders, which will be conducted via live webcast. The Special Meeting will be held in a virtual format only, via the Internet, with no physical in-person meeting. You will be able to attend the Special Meeting online and submit your questions during the meeting by visiting www.virtualshareholdermeeting.com/APDN2024SM. You will also be able to vote your shares electronically at the Special Meeting. We are pleased to use the latest technology to increase access, to improve communication and to obtain cost savings for our stockholders and the Company. Use of a virtual meeting will enable increased stockholder attendance and participation as stockholders can participate from any location. At the meeting, you will be asked to approve, in accordance with Nasdaq Listing Rule 5635(d), the exercisability of certain common stock purchase warrants and the issuance of the common stock underlying such warrants, which warrants were issued in connection with an offering of securities of the Company that occurred on May 28, 2024. Detailed information with respect to this matter is set forth in the accompanying Proxy Statement, which we encourage you to carefully read in its entirety. We look forward to greeting personally those stockholders who are able to attend the meeting online. However, whether or not you plan to join us at the meeting, it is important that your shares be represented. Stockholders of record at the close of business on June 3, 2024 are entitled to notice of and to vote at the meeting. Such stockholders are urged to promptly submit the enclosed proxy card, even if their shares were sold after the record date. You may vote over the Internet, as well as by telephone or by mail pursuant to instructions provided on the proxy card. Please review the instructions for each of your voting options described in the Proxy Statement. Thank you for your ongoing support of Applied DNA Sciences. Very truly yours, /s/ James A. Hayward James A. Hayward Chairman, President and Chief Executive Officer TABLE OF CONTENTS APPLIED DNA SCIENCES, INC. NOTICE OF SPECIAL MEETING OF STOCKHOLDERS Notice is hereby given that a Special Meeting of Stockholders (the " Special Meeting ") of Applied DNA Sciences, Inc. (" Applied DNA Sciences " or the " Company "), will be held online at 10:00 a.m., Eastern Time , on Friday, August 2, 2024 , for the following purposes: to approve, in accordance with Nasdaq Listing Rule 5635(d), the exercisability of certain common stock purchase warrants, and the issuance of the common stock underlying such warrants, which warrants were issued in connection with an offering of securities of the Company that occurred on May 28, 2024 (the " Warrant Exercise Proposal "); and to consider and act upon such other matters as may properly come before the meeting or any postponement or adjournment of the meeting. These matters are more fully described in the accompanying Proxy Statement. Only stockholders of record at the close of business on June 3, 2024 are entitled to notice of and to vote at the Special Meeting and any adjournment or postponement thereof. The Special Meeting will be held in a virtual format only, via the Internet, with no physical in-person meeting. Stockholders will have the ability to attend, vote and submit questions before and during the virtual meeting from any location via the Internet at www.virtualshareholdermeeting.com/APDN2024SM. A complete list of these stockh

View Full Filing

View this DEF 14A filing on SEC EDGAR